TABLE 1.
Solution/ program |
% of cell recovery |
% of GFP + cells |
% of UCH- L1 + cells |
% of GFP + UCH-L1 + cells from recovered cells |
% of GFP + UCH-L1 + from recovered UCH-L1 + cells |
% overall yieldb |
---|---|---|---|---|---|---|
V/X-005 | 49.7 ± 5.72a,1 | 39.6 ± 2.161 | 52.9 ± 5.951 | 31.5 ± 7.671 | 46.5 ± 2.251 | 15.2 ± 1.991 |
L/X-001 | 54.8± 5.571 | 25.9 ± 7.741 | 50.5 ± 3.051 | 19.6 ± 10.831,2 | 37.1 ± 8.291,2 | 10.5 ± 5.011,2 |
B/U-030 | 33.1 ± 6.782 | 34.3 ± 2.871 | 43.6 ± 12.661 | 15.2 ± 7.622 | 39.1 ± 3.072 | 4.8 ± 2.172 |
Within each column, different numbers indicate statistically significant difference (p < 0.05).
mean ± SD; n = 3 for V/X-005 and B/U-030; n = 4 for L/X-001.
% of GFP+ UCH-L1+ cells from input cells subjected to nucleofection.